You have 9 free searches left this month | for more free features.

Liposarcoma, Myxoid

Showing 51 - 75 of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

Active, not recruiting
  • Sarcoma
  • Dedifferentiated Liposarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 17, 2022

Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)

Recruiting
  • Leiomyosarcoma
  • Liposarcoma
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022

Dedifferentiated Liposarcoma Trial in Worldwide (RAIN-32, Trabectedin)

Active, not recruiting
  • Dedifferentiated Liposarcoma
  • Palo Alto, California
  • +70 more
Aug 4, 2022

Soft Tissue Sarcomas Trial in Zhengzhou (Anlotinib Hydrochloride)

Completed
  • Soft Tissue Sarcomas
  • Anlotinib Hydrochloride
  • Zhengzhou, Henan, China
    Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer
Mar 14, 2022

Liposarcoma, Dedifferentiated Trial (Brigimadlin)

Not yet recruiting
  • Liposarcoma, Dedifferentiated
  • (no location specified)
Sep 22, 2023

Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)

Recruiting
  • Liposarcoma
  • +5 more
  • Eribulin Mesylate
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 17, 2022

Dedifferentiated Liposarcoma Trial in Worldwide (Cabazitaxel)

Completed
  • Dedifferentiated Liposarcoma
  • Antwerpen, Belgium
  • +10 more
Sep 10, 2021

Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)

Recruiting
  • Advanced Dedifferentiated Liposarcoma
  • Jacksonville, Florida
  • +6 more
Jul 27, 2022

Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Trial in

Terminated
  • Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
  • Lille, France
  • +5 more
Dec 31, 2020

Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma Trial in Spain (Pazopanib)

Active, not recruiting
  • Solitary Fibrous Tumor
  • Extraskeletal Myxoid Chondrosarcoma
  • Palma De Mallorca, Islas Baleares, Spain
  • +6 more
Jan 31, 2022

Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

Completed
  • Rhabdoid Tumors
  • +3 more
  • Los Angeles, California
  • +34 more
Dec 23, 2021

Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in

Active, not recruiting
  • Dedifferentiated Liposarcoma
  • +5 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Liposarcoma, Leiomyosarcoma Trial in Italy (Trabectedin)

Completed
  • Liposarcoma
  • Leiomyosarcoma
  • Bari, BA, Italy
  • +20 more
Oct 29, 2021

Liposarcoma, Advanced Solid Tumor Trial in Guangzhou, Shanghai (APG-115, Toripalimab)

Recruiting
  • Liposarcoma
  • Advanced Solid Tumor
  • Guangzhou, Guangdong, China
  • +1 more
Sep 22, 2021

Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)

Terminated
  • Sarcoma
  • +3 more
  • CMB305
  • +2 more
  • Santa Monica, California
  • +7 more
Jun 29, 2020

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • San Francisco, California
  • +31 more
Jan 17, 2023

Liposarcoma Trial in Worldwide (HDM201, LEE011)

Completed
  • Liposarcoma
  • Toronto, Ontario, Canada
  • +8 more
Dec 6, 2020

Advanced and / or Metastatic Liposarcoma Trial in Germany, Spain (Pazopanib)

Completed
  • Advanced and / or Metastatic Liposarcoma
  • Berlin, Germany
  • +14 more
Jul 8, 2020

Sarcoma,Soft Tissue, Nasal Cavity Cancer, Paranasal Sinus Cancer Trial in Shanghai (endoscopic surgery)

Recruiting
  • Sarcoma,Soft Tissue
  • +3 more
  • endoscopic surgery
  • Shanghai, Shanghai, China
    Yu Hongmeng
Nov 7, 2022

Sarcoma Trial in Austria, France (Regorafenib, Placebo)

Completed
  • Sarcoma
  • Graz, Austria
  • +24 more
Apr 8, 2021

Liposarcoma Trial in France (Radiotherapy)

Completed
  • Liposarcoma
  • Radiotherapy
  • Strasbourg, Alsace, France
  • +4 more
Feb 22, 2021

Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
Nov 24, 2020

Liposarcoma Trial in Nice

Completed
  • Liposarcoma
    • Nice, France
      Nice Hospital
    Oct 15, 2020

    Soft Tissue Sarcoma Adult, Advanced Cancer Trial in Beijing (Apatinib)

    Withdrawn
    • Soft Tissue Sarcoma Adult
    • Advanced Cancer
    • Beijing, Beijing, China
    • +2 more
    May 15, 2020

    Soft Tissue Sarcoma Trial in Worldwide (Eribulin mesylate 1.4 mg/m^2 intravenous, Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or

    Completed
    • Soft Tissue Sarcoma
    • Eribulin mesylate 1.4 mg/m^2 intravenous
    • Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or 1,200 mg/m^2 IV
    • Tucson, Arizona
    • +118 more
    Jul 14, 2020